Logo image of EPSN

EPSILON ENERGY LTD (EPSN) Stock Fundamental Analysis

NASDAQ:EPSN - Nasdaq - CA2943752097 - Common Stock - Currency: USD

5.47  -1 (-15.46%)

After market: 5.6099 +0.14 (+2.56%)

Fundamental Rating

5

Overall EPSN gets a fundamental rating of 5 out of 10. We evaluated EPSN against 208 industry peers in the Oil, Gas & Consumable Fuels industry. While EPSN has a great health rating, its profitability is only average at the moment. EPSN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

EPSN had positive earnings in the past year.
EPSN had a positive operating cash flow in the past year.
EPSN had positive earnings in each of the past 5 years.
EPSN had a positive operating cash flow in each of the past 5 years.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

The Return On Assets of EPSN (3.54%) is comparable to the rest of the industry.
EPSN has a Return On Equity (4.45%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 5.62%, EPSN is in line with its industry, outperforming 49.04% of the companies in the same industry.
EPSN had an Average Return On Invested Capital over the past 3 years of 10.21%. This is significantly below the industry average of 23.51%.
The last Return On Invested Capital (5.62%) for EPSN is well below the 3 year average (10.21%), which needs to be investigated, but indicates that EPSN had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.54%
ROE 4.45%
ROIC 5.62%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

With a Profit Margin value of 11.18%, EPSN perfoms like the industry average, outperforming 59.13% of the companies in the same industry.
EPSN's Profit Margin has declined in the last couple of years.
EPSN has a Operating Margin of 26.81%. This is in the better half of the industry: EPSN outperforms 61.06% of its industry peers.
EPSN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 73.51%, EPSN belongs to the top of the industry, outperforming 85.58% of the companies in the same industry.
EPSN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.81%
PM (TTM) 11.18%
GM 73.51%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

EPSN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for EPSN has been reduced compared to 1 year ago.
The number of shares outstanding for EPSN has been reduced compared to 5 years ago.
EPSN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 3.54 indicates that EPSN is not in any danger for bankruptcy at the moment.
EPSN has a Altman-Z score of 3.54. This is amongst the best in the industry. EPSN outperforms 86.06% of its industry peers.
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.54
ROIC/WACC0.63
WACC8.98%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

EPSN has a Current Ratio of 1.66. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.66, EPSN is doing good in the industry, outperforming 70.67% of the companies in the same industry.
A Quick Ratio of 1.66 indicates that EPSN should not have too much problems paying its short term obligations.
The Quick ratio of EPSN (1.66) is better than 73.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.66
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

3. Growth

3.1 Past

EPSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.00%, which is quite impressive.
Measured over the past years, EPSN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.77% on average per year.
Looking at the last year, EPSN shows a small growth in Revenue. The Revenue has grown by 2.58% in the last year.
EPSN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.38% yearly.
EPS 1Y (TTM)20%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%75%
Revenue 1Y (TTM)2.58%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%59.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.23, the valuation of EPSN can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as EPSN.
The average S&P500 Price/Earnings ratio is at 26.93. EPSN is valued slightly cheaper when compared to this.
EPSN is valuated reasonably with a Price/Forward Earnings ratio of 11.17.
EPSN's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.31, EPSN is valued rather cheaply.
Industry RankSector Rank
PE 18.23
Fwd PE 11.17
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EPSN is valued a bit cheaper than 62.98% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.18
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

EPSN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

EPSN has a Yearly Dividend Yield of 3.93%. Purely for dividend investing, there may be better candidates out there.
The stock price of EPSN dropped by -21.52% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 6.34, EPSN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, EPSN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.93%

5.2 History

EPSN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

123.78% of the earnings are spent on dividend by EPSN. This is not a sustainable payout ratio.
DP123.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

More info and screens

EPSILON ENERGY LTD

NASDAQ:EPSN (8/14/2025, 7:35:41 PM)

After market: 5.6099 +0.14 (+2.56%)

5.47

-1 (-15.46%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-04 2025-11-04
Inst Owners63.82%
Inst Owner Change5.21%
Ins Owners4.76%
Ins Owner Change0.49%
Market Cap120.45M
Analysts82.86
Price Target8.57 (56.67%)
Short Float %2.61%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield 3.93%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP123.78%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-13 2025-06-13 (0.0625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.56%
Min EPS beat(2)-41.18%
Max EPS beat(2)26.05%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)16.19%
Min Revenue beat(2)-2.91%
Max Revenue beat(2)35.29%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-27.27%
EPS NQ rev (3m)-27.27%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.23
Fwd PE 11.17
P/S 3.03
P/FCF N/A
P/OCF 5.55
P/B 1.21
P/tB 1.21
EV/EBITDA 6.18
EPS(TTM)0.3
EY5.48%
EPS(NY)0.49
Fwd EY8.95%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.99
OCFY18.03%
SpS1.8
BVpS4.53
TBVpS4.53
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 4.45%
ROCE 9.16%
ROIC 5.62%
ROICexc 5.97%
ROICexgc 5.97%
OM 26.81%
PM (TTM) 11.18%
GM 73.51%
FCFM N/A
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexcg growth 3Y-47.2%
ROICexcg growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 212.4%
Cap/Sales 60.35%
Interest Coverage 608.25
Cash Conversion 99.07%
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 1.66
Altman-Z 3.54
F-Score7
WACC8.98%
ROIC/WACC0.63
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%75%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.58%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%59.1%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y114.8%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year539.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-107.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.67%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%